Anthony Lucci Selected Research

Neoadjuvant Therapy

1/2022	Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US.
10/2021	Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy.
10/2019	Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy.
1/2018	Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer.
1/2018	A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.
1/2018	Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.
10/2017	Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.
1/2017	Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery.
12/2015	Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer.
1/2014	Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony Lucci Research Topics

Disease

69	Neoplasms (Cancer) 05/2022 - 05/2005
59	Breast Neoplasms (Breast Cancer) 05/2022 - 11/2002
27	Inflammatory Breast Neoplasms 05/2022 - 12/2003
21	Melanoma (Melanoma, Malignant) 03/2022 - 06/2008
17	Neoplasm Metastasis (Metastasis) 01/2020 - 03/2006
10	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2019 - 01/2007
9	Pathologic Complete Response 01/2022 - 09/2006
7	Triple Negative Breast Neoplasms 01/2022 - 01/2014
7	Circulating Neoplastic Cells 11/2019 - 04/2013
4	Necrosis 12/2013 - 10/2011
2	Residual Neoplasm 01/2022 - 01/2018
2	Disease Progression 10/2021 - 01/2018
2	Neoplasm Micrometastasis 01/2016 - 09/2009
2	Carcinogenesis 11/2014 - 11/2002
2	Lymphedema (Milroy Disease) 12/2012 - 10/2010
2	Lobular Carcinoma 09/2012 - 06/2009
2	Lymphatic Metastasis 01/2012 - 06/2010
2	Wounds and Injuries (Trauma) 10/2010 - 06/2008
2	Postoperative Pain 11/2009 - 09/2009
2	Genomic Instability 06/2008 - 06/2007
1	Merkel Cell Carcinoma 03/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2022
1	Margins of Excision 10/2021
1	Tertiary Lymphoid Structures 01/2020
1	Adenocarcinoma 11/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2018
1	Hypoxia (Hypoxemia) 02/2018
1	Neutropenia 01/2018

Drug/Important Bio-Agent (IBA)

20	Estrogen ReceptorsIBA 10/2020 - 10/2005
13	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2014 - 11/2002
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
10	Hormones (Hormone)IBA 08/2021 - 02/2011
8	Progesterone Receptors (Progesterone Receptor)IBA 10/2020 - 10/2005
7	Biological ProductsIBA 05/2020 - 07/2010
6	Trastuzumab (Herceptin)FDA Link 04/2013 - 12/2003
5	human ERBB2 proteinIBA 08/2021 - 07/2010
5	Proteins (Proteins, Gene)FDA Link 09/2014 - 06/2008
4	Epidermal Growth Factor (EGF)IBA 10/2020 - 06/2007
4	Immune Checkpoint InhibitorsIBA 01/2020 - 11/2018
4	ErbB Receptors (EGF Receptor)IBA 10/2019 - 11/2009
4	Glutamine (L-Glutamine)FDA Link 06/2019 - 01/2012
4	LuciferasesIBA 04/2010 - 07/2006
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2022 - 04/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2022 - 06/2008
3	Phenobarbital (Luminal)FDA Link 01/2022 - 12/2010
3	Estrogens (Estrogen)FDA Link 12/2015 - 01/2011
3	ProstaglandinsIBA 09/2014 - 05/2005
3	Messenger RNA (mRNA)IBA 01/2013 - 06/2010
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2009 - 11/2002
2	Antineoplastic Agents (Antineoplastics)IBA 05/2022 - 01/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2018
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 03/2021 - 06/2019
2	C-Reactive ProteinIBA 01/2016 - 04/2015
2	Interleukin-12 Subunit p40IBA 09/2015 - 04/2015
2	MicroRNAs (MicroRNA)IBA 11/2014 - 07/2010
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2014 - 06/2008
2	Transcription Factors (Transcription Factor)IBA 02/2012 - 03/2010
2	PlasticsIBA 01/2012 - 06/2011
2	Celecoxib (Celebrex)FDA Link 10/2010 - 09/2005
2	Coloring Agents (Dyes)IBA 10/2010 - 04/2006
2	CTCE-9908IBA 04/2010 - 08/2009
2	Peptides (Polypeptides)IBA 04/2010 - 08/2009
2	Monoclonal AntibodiesIBA 09/2009 - 01/2007
2	Dinoprostone (PGE2)FDA Link 07/2006 - 04/2006
2	EnzymesIBA 05/2005 - 11/2002
1	JIB-04IBA 05/2022
1	Histone DemethylasesIBA 05/2022
1	Analgesics (Analgesic Drugs)IBA 03/2022
1	Opioid Analgesics (Opioids)IBA 03/2022
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 03/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	ParaffinIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Circulating Tumor DNAIBA 10/2021
1	Biological FactorsIBA 10/2020
1	Radium-223IBA 01/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2019
1	NivolumabIBA 11/2018
1	IpilimumabIBA 11/2018
1	Edetic Acid (EDTA)FDA Link 09/2018
1	cobaltous chloride (cobalt(II)chloride)IBA 02/2018
1	dabrafenibIBA 01/2018
1	130-nm albumin-bound paclitaxelIBA 01/2018

Therapy/Procedure

39	Therapeutics 05/2022 - 01/2006
16	Neoadjuvant Therapy 01/2022 - 09/2006
12	Radiotherapy 01/2022 - 01/2007
11	Mastectomy (Mammectomy) 08/2021 - 12/2004
9	Lymph Node Excision (Lymph Node Dissection) 03/2022 - 10/2005
9	Segmental Mastectomy (Lumpectomy) 01/2019 - 12/2004
8	Drug Therapy (Chemotherapy) 01/2022 - 12/2003
4	Immunotherapy 01/2022 - 12/2012
3	Mammaplasty (Breast Reconstruction) 04/2022 - 05/2011
2	Simple Mastectomy 01/2022 - 03/2011
2	Modified Radical Mastectomy (Mastectomy, Modified) 08/2021 - 11/2020
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018 - 12/2012
2	Operative Surgical Procedures 10/2016 - 09/2006
2	Conduction Anesthesia (Regional Anesthesia) 11/2009 - 09/2009